CTRI/2022/04/041621已完成未知
Evaluation of skin sensitization potential of investigational products by Human Repeat Insult Patch Test (HRIPT)
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male or female subjects 18 to 65 years of age
- •2. Subjects must be generally in good health as determined from a recent medical history which is on file with the investigator.
- •3. The ability of the subject to understand and sign a written informed consent form which must be obtained prior to treatment.
- •4. Subjects with skin type (Normal: Oily: Combination: Dry in the ratio of 1:1:1:1), and sensitive skin (dry sensitive skin: normal sensitive skin in the ration 1:1)
- •5. Willingness to avoid UV exposure (sun or artificial UV) on the test sites during the course of the study.
- •6. Subjects must have clear back. They should not have any infection or allergy on the tested area. They should have healthy skin on test area
- •7. Subjects should be cooperative, informed of the need and duration of the examination and ready to comply with the protocol procedures
- •8. Subjects having valid proof of identity and age.
- •9. Willingness to avoid excessive water contact (like swimming etc.) or activity
- •which causes excessive sweating (like exercise, sauna, etc.) during the course of study
- •10. Subjects with skin photo type III to V
排除标准
- •1. Pregnant women/ Nursing mothers
- •2. Scars excessive terminal hair or tattoo on the studied area.
- •3. Henna tattoo anywhere on the body (in case of studies involving hair dyes).
- •4. Dermatological infection/pathology on the level of studied area
- •5. Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye)
- •6. Any clinically significant systematic or cutaneous disease, which may interfere with study treatment or procedures
- •7. Chronic illness which may influence the outcome of the study.
- •8. Subject on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month)
- •9. Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.
- •10. Subjects having mole or hair on the back which may influence the study results as per the investigator and study coordinator decision
研究者
相似试验
已完成
Unknown
safety of the test product to be checkedCTRI/2023/11/059663HNL Business Services India Private Limited110
尚未招募
不适用
Repeat patch test on Humans with Normal Skin Type.CTRI/2020/06/025777Dabur India Limited
已完成
1 期
To evaluate the safety of test products.CTRI/2020/03/023725The Himalaya Drug Company200
已完成
1 期
To study the safety of test products on the skin.CTRI/2020/06/026085The Himalaya Drug Company200
尚未招募
Unknown
Assessment of safety of productCTRI/2024/07/070485Saffron Naturele Products Pvt Ltd
